Disclaimer: Publications may either be freely available or require a fee to view (or access) on the journal’s website.

Full Citation

Alping P, Askling J, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, Hillert J, Langer-Gould A, Lycke J, Nilsson P, Salzer J, Svenningsson A, Vrethem M, Olsson T, Piehl F, Frisell T. Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients. Ann Neurol. 2020 Feb 13. doi: 10.1002/ana.25701. [Epub ahead of print] PubMed PMID: 32056253.

Tags

Journal Article Type
Journal Publication Name
Literature Type